Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Pseudoacromegaly induced by the long-term use of minoxidil.

Nguyen KH, Marks JG Jr.

J Am Acad Dermatol. 2003 Jun;48(6):962-5.

PMID:
12789195
2.

Insulin-mediated "pseudoacromegaly".

Sam AH, Tan T, Meeran K.

Hormones (Athens). 2011 Apr-Jun;10(2):156-61.

3.

Insulin-mediated pseudoacromegaly: a case report and review of the literature.

Yaqub A, Yaqub N.

W V Med J. 2008 Sep-Oct;104(5):12-5. Review.

PMID:
18846753
4.

Stevens-Johnson syndrome associated with oral minoxidil: a case report.

Callen EC, Church CO, Hernandez CL, Thompson ED.

J Nephrol. 2007 Jan-Feb;20(1):91-3.

PMID:
17347980
5.

Primary hypothyroidism presenting as pseudoacromegaly.

Kumar KV, Shaikh A, Anwar I, Prusty P.

Pituitary. 2012 Dec;15 Suppl 1:S49-52. doi: 10.1007/s11102-011-0336-x.

PMID:
21805092
6.

Usefulness of the thyrotropin-releasing hormone test in pre-clinical acromegaly.

Kageyama K, Moriyama T, Sakihara S, Takayasu S, Nigawara T, Suda T.

Tohoku J Exp Med. 2005 Aug;206(4):291-7.

7.

Minoxidil-associated exudative pleural effusion.

Siddiqui A, Ansari M, Shakil J, Chemitiganti R.

South Med J. 2010 May;103(5):458-60. doi: 10.1097/SMJ.0b013e3181be3415. Erratum in: South Med J. 2010 Jul;103(7):721.

PMID:
20375958
8.

Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.

Carvalho LR, de Faria ME, Osorio MG, Estefan V, Jorge AA, Arnhold IJ, Mendonca BB.

Clin Endocrinol (Oxf). 2003 Dec;59(6):788-92.

PMID:
14974923
9.

[Acquired sebaceous hyperplasia of cutis verticis gyrata type sensitive to 13-cis-retinoid].

Blanchet-Bardon C, Servant JM, Le Tuan B, Puissant A.

Ann Dermatol Venereol. 1982;109(9):749-50. French. No abstract available.

PMID:
6961873
10.

Safe discontinuation of antihypertensive therapy.

Ahmad S.

Arch Fam Med. 1995 Sep;4(9):755. No abstract available.

PMID:
7647939
11.

[Effective treatment of refractory hypertension with minoxidil].

Holtzman E, Boichis H, Teicher A, Rosenthal T.

Harefuah. 1982 Dec 1;103(11):300-3. Hebrew. No abstract available.

PMID:
7182337
12.

Minoxidil, hypercoagulability and thromboembolic disease of the lung.

Keohane SG, Edmunds M, Holton J, Swales JD.

Postgrad Med J. 1996 Apr;72(846):229-30.

13.

Fatal toxic epidermal necrolysis associated with minoxidil.

Karaoui LR, Chahine-Chakhtoura C.

Pharmacotherapy. 2009 Apr;29(4):460-7. doi: 10.1592/phco.29.4.460.

PMID:
19323621
14.

[Essential primary cutis verticis gyrata]

Schenato LK, Gil T, Carvalho LA, Ricachnevsky N, Sanseverino A, Halpern R.

J Pediatr (Rio J). 2002 Jan-Feb;78(1):75-80. Portuguese.

15.

[Pachydermoperiostosis--report of a case and review of 121 Japanese cases].

Matsui Y, Nishii Y, Maeda M, Okada N, Yoshikawa K.

Nihon Hifuka Gakkai Zasshi. 1991 Mar;101(4):461-7. Review. Japanese.

PMID:
1909389
16.

Acromegaly presenting as cutis verticis gyrata.

Al-Bedaia M, Al-Khenaizan AS.

Int J Dermatol. 2008 Feb;47(2):164. doi: 10.1111/j.1365-4632.2008.03350.x.

PMID:
18211488
17.

Pseudofolliculitis barbae induced by oral minoxidil.

Liew HM, Morris-Jones R, Diaz-Cano S, Bashir S.

Clin Exp Dermatol. 2012 Oct;37(7):800-1. doi: 10.1111/j.1365-2230.2012.04376.x. Epub 2012 May 21. No abstract available.

PMID:
22607496
18.

Very large pericardial effusion attributable to minoxidil: resolution without drainage of fluid.

Shirwany A, D'Cruz IA, Munir A.

Echocardiography. 2002 Aug;19(6):513-6.

PMID:
12356348
19.

Acromegaly associated with type 2 diabetes showing normal IGF-1 levels under poorly controlled glycemia.

Lim DJ, Kwon HS, Cho JH, Kim SH, Choi YH, Yoon KH, Cha BY, Lee KW, Son HY, Kang SK.

Endocr J. 2007 Aug;54(4):537-41. Epub 2007 Jun 13.

20.

Minoxidil: an underused vasodilator for resistant or severe hypertension.

Sica DA.

J Clin Hypertens (Greenwich). 2004 May;6(5):283-7. Review.

Supplemental Content

Support Center